Average Co-Inventor Count = 11.55
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (8 from 125 patents)
2. Eisai R&d Management Co., Ltd. (5 from 528 patents)
3. Eisai Company, Limited (1 from 677 patents)
4. Valo Health, Inc. (1 from 29 patents)
5. Valo Early Discovery, Inc. (1 from 15 patents)
16 patents:
1. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
2. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
3. 10464910 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
4. 10464909 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
5. 10457652 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
6. 10442776 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
7. 10421732 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
8. 10214500 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
9. RE47193 - Selectively substituted quinoline compounds
10. 9637453 - 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors
11. 9630922 - 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors
12. 9428495 - Selectively substituted quinoline compounds
13. 8691814 - Deazapurines and uses thereof
14. 7868002 - Deazapurines and uses thereof
15. 7666875 - Hydantoin compounds